Why Join:

As per the McKinsey Global Institute's (MGI) recent report, it has been estimated that Generative AI technology could generate $60 billion to $110 billion a year in economic value for the pharma and medical-tech industries.  

In this webinar, you can explore how Generative AI can be effectively utilized within the life sciences industry to accelerate drug discovery and reduce the overall TCO. Explore life science-specific use cases, assess their value and feasibility, and examine their practical applications across diverse functional domains.

Topics that will be covered in this webinar:

• Exclusive First Look: Structured framework for Generative AI use cases in life sciences, empowering industry leaders for a systematic approach to Generative AI
• Discover the extensive benefits and potential outcomes of real-world applications of Generative AI
• Learn how Agilisium applied its Generative AI Solution to accelerate Medical Writing by 30% in Drug Development for its Global 2000 Pharma Customer.
• Agilisium: Introduction and Life Science Capabilities